Effect of Octreotide in Treating Advanced Cholangiocarcinoma
Author Information
Author(s): Kiki Pistevou-Gompaki, Nikos Eleftheriadis, Christos Papaloukas, Damianos Eleftheriadis
Primary Institution: Aristotle’s University of Thessaloniki, Greece
Hypothesis
Can octreotide stabilize disease and improve quality of life in patients with end-stage cholangiocarcinoma?
Conclusion
Octreotide may be effective in stabilizing disease and improving pain management in patients with end-stage cholangiocarcinoma.
Supporting Evidence
- Both patients reported a decrease in pain after starting octreotide treatment.
- Bilirubin levels normalized within a few days after treatment.
- Octreotide was well-tolerated with only mild side effects.
Takeaway
This study looked at two patients with a tough type of cancer and found that a medicine called octreotide helped them feel better and hurt less.
Methodology
The study involved two patients treated with octreotide and monitored for pain and bilirubin levels over six months.
Limitations
The study had a small sample size and lacked a control group.
Participant Demographics
Two male patients aged 63 and 81 with advanced cholangiocarcinoma.
Want to read the original?
Access the complete publication on the publisher's website